v3.26.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2024 $ 16 $ 1,206,412 $ (891,084) $ 315,344
Balance, shares at Dec. 31, 2024 157,749,490      
Stockholders' Equity (Deficit)        
Issuance of common stock upon exercise of stock options   4,183   4,183
Issuance of common stock upon exercise of stock options, shares 880,115      
Issuance of common stock upon vesting of restricted stock units, shares 632,419      
Stock-based compensation expense   10,456   10,456
Net Income (Loss)     (64,053) (64,053)
Balance at Mar. 31, 2025 $ 16 1,221,051 (955,137) 265,930
Balance, shares at Mar. 31, 2025 159,262,024      
Balance at Dec. 31, 2024 $ 16 1,206,412 (891,084) 315,344
Balance, shares at Dec. 31, 2024 157,749,490      
Stockholders' Equity (Deficit)        
Net Income (Loss)       (131,867)
Balance at Jun. 30, 2025 $ 17 1,328,850 (1,022,951) 305,916
Balance, shares at Jun. 30, 2025 172,925,389      
Balance at Mar. 31, 2025 $ 16 1,221,051 (955,137) 265,930
Balance, shares at Mar. 31, 2025 159,262,024      
Stockholders' Equity (Deficit)        
Issuance of common stock upon exercise of stock options   3,384   3,384
Issuance of common stock upon exercise of stock options, shares 697,692      
Issuance of common stock in connection with employee stock purchase plan   713   713
Issuance of common stock in connection with employee stock purchase plan, shares 96,007      
Issuance of common stock upon vesting of restricted stock units, shares 229,154      
Issuance of common stock upon exercise of pre-funded warrants, shares, cashless 1,092,148      
Issuance of common stock upon public offering, net of issuance costs $ 1 94,024   94,025
Issuance of common stock upon public offering, net of issuance costs, shares 11,548,364      
Stock-based compensation expense   9,678   9,678
Net Income (Loss)     (67,814) (67,814)
Balance at Jun. 30, 2025 $ 17 1,328,850 (1,022,951) 305,916
Balance, shares at Jun. 30, 2025 172,925,389      
Balance at Dec. 31, 2025 $ 22 1,811,311 (1,157,023) 654,310
Balance, shares at Dec. 31, 2025 215,927,600      
Stockholders' Equity (Deficit)        
Issuance of common stock upon exercise of stock options   294   294
Issuance of common stock upon exercise of stock options, shares 50,379      
Issuance of common stock upon vesting of restricted stock units, shares 1,169,636      
Issuance of common stock upon exercise of pre-funded warrants, shares, cashless 1,749,300      
Stock-based compensation expense   15,582   15,582
Net Income (Loss)     (88,612) (88,612)
Balance at Mar. 31, 2026 $ 22 1,827,187 (1,245,635) 581,574
Balance, shares at Mar. 31, 2026 218,896,915      
Balance at Dec. 31, 2025 $ 22 1,811,311 (1,157,023) 654,310
Balance, shares at Dec. 31, 2025 215,927,600      
Stockholders' Equity (Deficit)        
Net Income (Loss)       (167,375)
Balance at Jun. 30, 2026 $ 22 1,844,417 (1,324,398) 520,041
Balance, shares at Jun. 30, 2026 219,589,303      
Balance at Mar. 31, 2026 $ 22 1,827,187 (1,245,635) 581,574
Balance, shares at Mar. 31, 2026 218,896,915      
Stockholders' Equity (Deficit)        
Issuance of common stock upon exercise of stock options   1,679   1,679
Issuance of common stock upon exercise of stock options, shares 291,329      
Issuance of common stock in connection with employee stock purchase plan   902   902
Issuance of common stock in connection with employee stock purchase plan, shares 107,981      
Issuance of common stock upon vesting of restricted stock units, shares 293,078      
Stock-based compensation expense   14,649   14,649
Net Income (Loss)     (78,763) (78,763)
Balance at Jun. 30, 2026 $ 22 $ 1,844,417 $ (1,324,398) $ 520,041
Balance, shares at Jun. 30, 2026 219,589,303